Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination
- PMID: 14571216
- DOI: 10.1067/S0022-3476(03)00331-7
Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination
Erratum in
- J Pediatr. 2004 Mar;144(3):412
Abstract
Rates and severity of pneumococcal infections in children with sickle cell disease were examined before licensure of pneumococcal-conjugated vaccine (PVC). Rates of peak invasive infection rates in 1-year-old children with hemoglobin SS and mortality in those 0 to 10 years of age were 36.5 to 63.4 and 1.4 to 2.8 per 1000 person-years, respectively (>10 and 100 times as frequent as in the general population). Overall, 71% of serotyped isolates (n=80) were PVC serotypes and 71% of nonvaccine serotype strains were penicillin-sensitive. Clinical presentation in children with hemoglobin SS (n=71; more with hypotension) and hemoglobin SC (n=18; more with acute chest syndrome, otitis media) differed. Penicillin nonsusceptibility (38% of isolates) varied between geographic study sites. Penicillin prophylaxis appeared less effective against intermediate and resistant strains. Of all infected children, meningitis developed in 20% and 15% died (hemoglobin SS, n=15 and 11; hemoglobin SC, n=1 each). Factors associated with death included age >4 years (58%), serotype 19F, and not being followed by a hematologist (42% each). The pneumococcal-polysaccharide vaccine was 80.4% effective within 3 years after vaccination (95% CI, 39.7, 93.6). Children with sickle cell disease of all ages may benefit from PVC boosted with polysaccharide vaccination.
Comment in
-
Prevention of invasive pneumococcal infection in sickle cell disease: on the threshold of a new era of successes?J Pediatr. 2003 Oct;143(4):423-5. doi: 10.1067/S0022-3476(03)00466-9. J Pediatr. 2003. PMID: 14571211 No abstract available.
Similar articles
-
Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.Pediatrics. 2008 Mar;121(3):562-9. doi: 10.1542/peds.2007-0018. Pediatrics. 2008. PMID: 18310206
-
7-valent pneumococcal conjugate vaccine: new preparation. Prevents rare invasive infections in infants.Prescrire Int. 2002 Feb;11(57):7-10. Prescrire Int. 2002. PMID: 11985376
-
Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001. Clin Infect Dis. 2008. PMID: 18627249
-
Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.Clin Microbiol Infect. 2009 Apr;15 Suppl 3:4-6. doi: 10.1111/j.1469-0691.2009.02723.x. Clin Microbiol Infect. 2009. PMID: 19366362 Review.
-
Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Int J Antimicrob Agents. 2008. PMID: 18378430 Review.
Cited by
-
Penicillin prophylaxis in children with sickle cell disease.J Pediatr Pharmacol Ther. 2010 Jul;15(3):152-9. J Pediatr Pharmacol Ther. 2010. PMID: 22477807 Free PMC article.
-
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study.Blood Adv. 2023 Feb 14;7(3):414-421. doi: 10.1182/bloodadvances.2022008037. Blood Adv. 2023. PMID: 36383730 Free PMC article. Clinical Trial.
-
Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease.Antimicrob Agents Chemother. 2018 Mar 27;62(4):e00637-17. doi: 10.1128/AAC.00637-17. Print 2018 Apr. Antimicrob Agents Chemother. 2018. PMID: 29378711 Free PMC article.
-
Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease.Adv Exp Med Biol. 2017;1013:59-87. doi: 10.1007/978-1-4939-7299-9_3. Adv Exp Med Biol. 2017. PMID: 29127677 Free PMC article. Review.
-
Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009.Pediatr Infect Dis J. 2013 Dec;32(12):1308-12. doi: 10.1097/INF.0b013e3182a11808. Pediatr Infect Dis J. 2013. PMID: 23811745 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical